We previously demonstrated that in vivo estradiol treatment markedly a
ttenuates alpha(2)-adrenoceptor function and coupling to G-proteins in
the hypothalamus of female rats. Ligand binding studies indicated tha
t 48 h exposure to estradiol decreases the number of alpha(2)-adrenerg
ic receptors in the agonist high affinity state. In the present studie
s, when [H-3]RX821002 was used to label brain alpha(2)-adrenoceptors,
the density of binding sites significantly increased in the hypothalam
us and preoptic area 48 h after estrogen treatment. Moreover, the ther
modynamics of ligand binding to alpha(2)-adrenergic receptors in membr
anes of female rat hypothalamus were modified by the same estradiol tr
eatments that reduce alpha(2)-adrenoceptor function. In hypothalamic m
embranes from ovariectomized control rats, antagonist (RX821002)-recep
tor binding was primarily entropy-driven while agonist (oxymetazoline)
binding had a higher enthalpy component. In membranes from estradiol-
exposed animals, the entropic contribution to both agonist and antagon
ist binding was markedly increased, and the enthalpy component was red
uced. Since the thermodynamic characteristics of ligand-receptor bindi
ng are strongly correlated with efficacy in activating signal transduc
tion [36], these data raise the intriguing possibility that steroids r
egulate transmembrane signaling by stabilization of a receptor conform
ation with reduced intrinsic efficacy.